Match Document Document Title Score
US20020031562 Recovery of gaultherin from plants  
The present invention provides methods for obtaining gaultherin, a natural salicylate derivative, from plant tissue. The methods involve preventing the hydrolysis of the gaultherin in the plant...
83
4757060 Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers  
A pharmaceutical composition and process for administering non-steroidal drugs which are protected against injury to the gastrointestinal tract by a combination of certain H1 and H2 receptor blockers.
83
US20090036412 Methods and Compositions for Inhibition of Angiogenesis  
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs,...
83
8906894 Methods for preventing and treating thrombotic disorders  
Compositions and methods for anti-thrombotic and antiplatelet therapy in a subject are provided. Administration of an MAO-B inhibitor results in reduced platelet aggregation or reversion of...
83
US20140094519 LIPOXIN ANALOGS AS NOVEL INHIBITORS OF ANGIOGENESIS  
The present invention is generally drawn to novel isolated therapeutic agents, termed lipoxins, generated from the interaction between a dietary omega-6 polyunsaturated fatty acid (PUFA) such as...
83
US20190216720 METHODS AND COMPOSITIONS FOR TREATING MIGRAINE AND CONDITIONS ASSOCIATED WITH PAIN  
The present invention relates to pharmaceutical compositions of a non-steroidal anti-inflammatory drug (NSAIDs) such as, aspirin, diclofenac, ibuprofen, ketoprofen, or naproxen, or any...
82
US20100105772 USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESIS  
The present invention is generally drawn to novel isolated therapeutic agents, termed lipoxins, generated from the interaction between a dietary omega-6 polyunsaturated fatty acid (PUFA) such as...
82
US20170266106 METHODS AND COMPOSITIONS FOR TREATING MIGRAINE AND CONDITIONS ASSOCIATED WITH PAIN  
The present invention relates to pharmaceutical compositions of an non-steroidal anti-inflammatory drug (NSAIDs) such as, aspirin, diclofenac, ibuprofen, ketoprofen, or naproxen, or any...
82
4666701 Pharmaceutical and dietary compositions  
Gamma-linolenic acid or dihomo-gamma-linolenic acid for use in the reduction or prevention of gastro-intestinal bleeding and other side effects shown by NSAIDs when administered on a continuing...
82
4080447 Therapeutic composition having an inhibiting activity on blood plate aggregation  
This invention relates to a therapeutic composition comprising, as active ingredient, a combination of 5-(2-chloro-benzyl)-4,5,6,7-tetrahydro-thieno[3,2-c]-pyridin e and acetylsalicylic acid, the...
82
6383515 Solvent system for enhancing solubility  
A pharmaceutically acceptable solution with a medicament suitable for filling a soft gelatin capsule is made from a solvent. The solvent contains a polymer, such as polyethylene glycol, and an...
81
US20010007668 SOLVENT SYSTEM FOR ENHANCING SOLUBILITY  
A pharmaceutically acceptable solution with a medicament suitable for filling a soft gelatin capsule is made from a solvent. The solvent contains a polymer, such as polyethylene glycol, and an...
81
US20020187195 Solvent system for enhancing solubility  
A pharmaceutically acceptable solution with a medicament suitable for filling a soft gelatin capsule is made from a solvent. The solvent contains a polymer, such as polyethylene glycol, and an...
81
5582837 Alkyl-substituted cellulose-based sustained-release oral drug dosage forms  
Sustained release oral drug dosage forms that comprise a tablet or capsule containing a plurality of particles of a solid-state drug dispersed in alkyl cellulose such as hydroxyethylcellulose or...
81
US20120220657 SYNERGISTIC ANTI-INFLAMMATORY AND ANTIOXIDANT DIETARY SUPPLEMENT COMPOSITIONS  
Disclosed herein are novel dietary supplement compositions comprising enriched 3-O-acetyl-11-keto-β-boswellic acid and enriched demethylated curcuminoids, wherein the composition exhibits...
81
8420132 Synergistic anti-inflammatory and antioxidant dietary supplement compositions  
Disclosed herein are novel dietary supplement compositions comprising enriched 3-O-acetyl-11-keto-β-boswellic acid and enriched demethylated curcuminoids, wherein the composition exhibits...
81
US20140147448 NOVEL COMPOSITIONS AND METHODS OF PREVENTING OR AMELIORATING ABNORMAL THROMBUS FORMATION AND CARDIOVASCULAR DISEASE  
The invention includes compositions and methods useful for treating preventing abnormal thrombus formation and subsequent cardiovascular disease in diabetic patients and patients with increased...
81
US20190105356 SYSTEMS AND METHODS FOR THROMBOSIS PREVENTION  
The disclosure provides a composition for inhibiting thrombosis. The composition includes 5 to 25% by weight of Fish Oil, 15 to 55% by weight of Willow Bark Extract, and 0.2 to 5% by weight of...
81
9364439 Pharmaceutical compositions for the coordinated delivery of NSAIDs  
The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The...
80
US20080027022 METHOD TO TREAT GASTRIC LESIONS  
The present invention provides a therapeutic method for treating gastric lesions, including administration to a patient in need thereof of an effective amount of an A2A adenosine receptor agonist....
80
US20130209441 PROCESS FOR INHIBITION OF CEREBRAL DAMAGE ASSOCIATED WITH ISCHEMIA BY ANTHOCYANINS AND ANTHOCYANIDINS  
A process is provided for inhibition of neural damage associated with an ischemic event that includes the administration of anthocyanin compound to a subject. After allowing sufficient time for...
80
10407612 Low PH crosslinking of polymers  
The invention is directed to polymers that self-crosslink at acidic pH or can be crosslinked by phenolic agents in brine. Such polymers have lower viscosity and can be pumped deep into reservoirs,...
80
US20090131377 Combinations of Superoxide Dismutase Mimetics and Nonsteroidal Analgesic/Anti-Inflammatory Drugs  
Combinations of synthetic low molecular weight catalysts for the dismutation of superoxide and Nonsteroidal Analgesic/Anti-Inflammatory Drugs (NSAIDs) are potent analgesics that are effective in...
79
US20060270639 Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs  
Combinations of synthetic low molecular weight catalysts for the dismutation of superoxide and Nonsteroidal Analgesic/Anti-Inflammatory Drugs (NSAIDs) are potent analgesics that are effective in...
79
US20190091155 COMBINATION TABLET WITH CHEWABLE OUTER LAYER  
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa...
79
US20170042821 COMBINATION TABLET WITH CHEWABLE OUTER LAYER  
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa...
79
7033618 Methods of administering gaultherin-containing compositions  
The present disclosure provides methods for obtaining gaultherin, a natural salicylate derivative, from plant tissue. The methods involve preventing the hydrolysis of the gaultherin in the plant...
77
US20160030354 COMBINATION TABLET WITH CHEWABLE OUTER LAYER  
A pharmaceutical composition in the form of a combination tablet is described. The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, oral mucosa...
77
4775536 Enteric coated tablet and process for making  
An enteric coated tablet and process is described in which a core tablet of a pharmaceutically active ingredient is provided with an enteric coating layer of a film forming enteric polymer and an...
77
US20100292280 ANTI-PYRETIC VASODILATORS  
The invention provides vasodilating medication as means for lowering fever when administered to humans in need of such treatment. In particular, the use of B3 vitamin substances and Nitric...
77
7252208 Tablet dispenser  
A compact, portable tablet dispenser is particularly adapted for carrying aspirin tablets for ingestion as therapy upon the onset of a suspected heart attack. The tablets are in a blister within...
75
US20150374835 LIQUID TOPICAL PHARMACEUTICAL NANO-EMULSION FORMULATIONS  
Aspects of the present invention are directed to compositions that are useful for delivery of an active ingredient to a subject. Some embodiments are formulated with an active ingredient,...
75
9532945 Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor  
The present disclosure provides oral dosage forms comprising an antiplatelet agent and an enterically coated acid inhibitor, as well as methods of treating subjects with an antiplatelet agent and...
75
4713031 Submerged bobber release device for fishing rods and the like  
The device includes a tubular housing open at one end and closed at the other end by an adhesively attached cup-shaped cap. Within the closed end is a well having a bottom formed with a slot...
74
8445030 Persistent and fast acting antiseptics and disinfectants based on calcium fluoride  
Antiseptic compounds that act as persistent and fast acting antiseptics and disinfectants. The base of these antiseptic actions is CaF2 as the persistent part, preventing the colonization of...
74
US20050035150 LID-LESS, squeeze-to-open, self-closing, pill-box  
An improved hand held thermoplastic multi-purpose lid-less airtight container, that can be squeezed open by the same hand for dispensing when up-ended, and automatically self-closes upon release...
74
7109206 Methods and compositions for the rapid and enduring relief of inadequate myocardial function  
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse...
74
5681577 Multiple action cold/sinus preparations  
A chewable cold/sinus preparation comprising a bitter tasting mixture of a decongestant such as pseudoephedrine and an antihistamine such as diphenhydramine and/or chlorpheniramine maleate is made...
73
7614496 Aqueous solution of an analgesic and a dispenser therefor  
A bottle cap is adapted to retain a quantity of an additive, such as for example aspirin or the like. The additive is retained in an isolated condition within a sealed chamber or within a bladder...
73
6140319 Vasopeptidase inhibitors to treat angina pectoris  
Vasopeptidaes inhibitors, especially omapatrilat, are useful in treating and/or relieving the symptoms of angina pectoris. The vasopeptidase inhibitor may be used in combination with other...
73
US20060233877 Betaine compositions  
The invention refers to the pharmaceutical combination including at least: a first compound selected among the group consisting of acetylsalicylic acid, salicylic acid, pharmaceutical derivatives...
73
4985241 Therapeutic combination of free-radical scavenger and tumor necrosis factor  
Damage to cells, tissue and other body parts in a mammalian host may be treated by using a lymphokine or cytotoxin in conjunction with at least one biological modifier, which may be a free radical...
73
7585856 Resolvins: Biotemplates for novel therapeutic interventions  
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
73
US20060293279 Administration of enoxaparin sodium to patients with severe renal impairment  
Methods having novel enoxaparin sodium dosing regimens for patients with severe renal impairment are disclosed. The methods may be used for one or more of preventing thrombotic episodes, treating...
72
US20120135050 EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
72
US20040198839 Cardioprotective dosage units  
A single dosage medication formulation incorporating a beta-adrenergic antagonist and an agent to prevent platelet aggregation to enhance simplicity, convenience, and compliance with the use of...
72
US20030161898 Methods of administering gaultherin-containing compositions  
The present disclosure provides methods for obtaining gaultherin, a natural salicylate derivative, from plant tissue. The methods involve preventing the hydrolysis of the gaultherin in the plant...
72
US20150342989 COMPOSITIONS COMPRISING NON STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF  
The invention provides analgesic, antipyretic, anti-inflammatory, and anti-neoplastic compositions containing epilactose in combination with non-steroidal anti-inflammatory drugs and...
72
6159993 Methods and compositions for the rapid and enduring relief of inadequate myocardial function  
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse...
71
US20020016312 Methods and compositions for the rapid and enduring relief of inadequate myocardial function  
Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse...
71


Search
« search again